CCL2 and rheumatoid arthritis: As shown in Fig. 3C – F, in human RA-FLS, KMU-11342 inhibited the LPS-induced production of various chemokines, such as CXCL10, CCL2, CCL3, and CCL4, which are highly expressed in RA [41].